Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Forner

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 23, 2023
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxideSara Ortiz-Rivero, Ana Peleteiro-Vigil, Lorena Abete, et al.
Cancers|September 14, 2024
Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current ControversiesEzequiel Mauro, Marco Sanduzzi-Zamparelli, Gabrielle Jutras, et al.
Journal of Hepatology|November 21, 2021
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateMaria Reig, Alejandro Forner, Jordi Rimola, et al.
Cancers|July 14, 2023
Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric PredictionSergio Muñoz-Martínez, Victor Sapena, Ángeles García-Criado, et al.
United European Gastroenterology Journal|July 6, 2021
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugsÁlvaro Díaz-González, Víctor Sapena, Loreto Boix, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 15, 2020
Hepatic epithelioid hemangioendothelioma: An international multicenter studyMarco Sanduzzi-Zamparelli, Jordi Rimola, Carla Montironi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 6, 2020
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trialsÁlvaro Díaz-González, Víctor Sapena, Loreto Boix, et al.
Hepatology (Baltimore, Md.)|October 19, 2020
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging SystemAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Open Forum Infectious Diseases|April 21, 2025
Dolutegravir-based Antiretroviral Therapy in People With HIV With Solid Organ Transplantation: A Single-arm Pilot Clinical Trial (DTG-SOT)Jose M Miro, Daniela Malano-Barletta, Leire Berrocal, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 14, 2023
Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavirRuben Gonzalez-García, Joan-Ramon Roma, María Rodríguez-García, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 23, 2023
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxideSara Ortiz-Rivero, Ana Peleteiro-Vigil, Lorena Abete, et al.
Cancers|September 14, 2024
Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current ControversiesEzequiel Mauro, Marco Sanduzzi-Zamparelli, Gabrielle Jutras, et al.
Journal of Hepatology|November 21, 2021
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateMaria Reig, Alejandro Forner, Jordi Rimola, et al.
Cancers|July 14, 2023
Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric PredictionSergio Muñoz-Martínez, Victor Sapena, Ángeles García-Criado, et al.
United European Gastroenterology Journal|July 6, 2021
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugsÁlvaro Díaz-González, Víctor Sapena, Loreto Boix, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 15, 2020
Hepatic epithelioid hemangioendothelioma: An international multicenter studyMarco Sanduzzi-Zamparelli, Jordi Rimola, Carla Montironi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 6, 2020
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trialsÁlvaro Díaz-González, Víctor Sapena, Loreto Boix, et al.
Hepatology (Baltimore, Md.)|October 19, 2020
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging SystemAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Open Forum Infectious Diseases|April 21, 2025
Dolutegravir-based Antiretroviral Therapy in People With HIV With Solid Organ Transplantation: A Single-arm Pilot Clinical Trial (DTG-SOT)Jose M Miro, Daniela Malano-Barletta, Leire Berrocal, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 14, 2023
Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavirRuben Gonzalez-García, Joan-Ramon Roma, María Rodríguez-García, et al.
Pageof 11